Rakuten Investment Management Inc. Buys Shares of 41,600 Humana Inc. $HUM

Rakuten Investment Management Inc. purchased a new position in shares of Humana Inc. (NYSE:HUM) during the third quarter, Holdings Channel reports. The institutional investor purchased 41,600 shares of the insurance provider’s stock, valued at approximately $10,823,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in HUM. Elevation Point Wealth Partners LLC bought a new position in Humana during the 2nd quarter worth about $32,000. Mather Group LLC. bought a new position in shares of Humana during the third quarter valued at approximately $34,000. AlphaCore Capital LLC bought a new position in Humana in the second quarter worth approximately $39,000. Private Wealth Management Group LLC lifted its holdings in Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after buying an additional 48 shares during the period. Finally, SJS Investment Consulting Inc. boosted its position in Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after acquiring an additional 193 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

HUM opened at $270.32 on Thursday. The company has a market cap of $32.51 billion, a P/E ratio of 25.33, a price-to-earnings-growth ratio of 2.21 and a beta of 0.45. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68. The firm’s 50-day moving average price is $257.11 and its 200-day moving average price is $264.26. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35.

Humana (NYSE:HUM) last released its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. Humana’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the business earned $4.16 EPS. As a group, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. Humana’s payout ratio is 33.18%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Morgan Stanley reissued an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. Bank of America boosted their target price on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Wells Fargo & Company lowered shares of Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Barclays reaffirmed an “underperformer” rating on shares of Humana in a research report on Monday, January 5th. Finally, Robert W. Baird decreased their target price on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $293.37.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.